| Literature DB >> 27908327 |
Abstract
Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis. Published by Elsevier Inc.Entities:
Keywords: Biomarkers; Lactate; Proadrenomedullin; Procalcitonin; Sepsis; Troponin
Mesh:
Substances:
Year: 2017 PMID: 27908327 DOI: 10.1016/j.emc.2016.09.004
Source DB: PubMed Journal: Emerg Med Clin North Am ISSN: 0733-8627 Impact factor: 2.264